The A to Z of pharmaceutical cocrystals: a decade of fast-moving new science and patents.
From aspirin to zoledronic acid, pharmaceutical cocrystals emerged in the past decade as a promising new weapon in the arsenal of drug development. Resurgence of interest in multicomponent crystal compositions has led to significant advances in the science of cocrystal design and discovery. These advances have built upon crystal engineering, which provides a deep understanding of supramolecular interactions between molecules that govern crystal packing and physicochemical properties of crystalline materials. Concomitantly, the patent landscape of pharmaceutical cocrystals developed rapidly in the last decade. This review presents a broad survey of patents issued in the area of pharmaceutical cocrystals. In addition, the review contains analyses of key patents in the area involving compositions and methodologies. Along the way, the main events of the past decade representing a renaissance of cocrystals of pharmaceutical materials are chronicled. Future directions in the area are discussed in light of key pending patent applications and recent publications of seminal interest.
Alkermes, Inc. 852 Winter Street, Waltham, MA 02451, USA. orn.almarsson@alkermes.com.
Örn
Ö
Almarsson
Matthew L
ML
Peterson
Michael
M
Zaworotko
D002626:Chemistry, Pharmaceutical; D003460:Crystallization; D015195:Drug Design; D006801:Humans; D010330:Patents as Topic; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000737:chemistry*
D004364:Pharmaceutical Preparations